Benzinga | Mar 9, 2021 09:16AM EST

Credit Suisse Initiates Coverage On Hims & Hers Health with Neutral Rating, Announces Price Target of $16

Credit Suisse analyst Jailendra Singh initiates coverage on Hims & Hers Health (NYSE:HIMS) with a Neutral rating and announces Price Target of $16.